Parkinson Disease: all 4,583 studies

Page 15 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.

• Randomized Safety Study of CVT-301 Compared to an Observational Control GroupCompletedNCT02352363Phase 3Results posted
• The Role of Cerebellar Hyperactivity in Parkinson's DiseaseCompletedNCT02349789Results posted
• Cognitive Dysfunction in Parkinson's DiseaseCompletedNCT02346708Not applicableResults posted
• A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337764Phase 3Results posted
• A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsCompletedNCT02337751Phase 3Results posted
• A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337738Phase 2/3Results posted
• A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease PatientsCompletedNCT02337725Phase 3Results posted
• Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of OpicaponeCompletedNCT02305316Phase 1Results posted
• Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy VolunteersCompletedNCT02305017Phase 1Results posted
• Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's DiseaseCompletedNCT02289729Results posted
• Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced DyskinesiaCompletedNCT02274766Phase 3Results posted
• Transcranial Direct Current Stimulation for Freezing of GaitTerminatedNCT02266004Not applicableResults posted
• ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's DiseaseCompletedNCT02263885Not applicableResults posted
• SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)CompletedNCT02258152Phase 2Results posted
• Telemedicine Intervention to Improve Cognitive FunctionCompletedNCT02248649Not applicableResults posted
• ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's DiseaseCompletedNCT02246374Not applicableResults posted
• Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesCompletedNCT02242487Phase 3Results posted
• Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesCompletedNCT02240030Phase 3Results posted
• Effect of Levodopa on Postural Motor Learning in Parkinson DiseaseCompletedNCT02239978Results posted
• A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's DiseaseCompletedNCT02230904Phase 1Results posted
• A Study to Examine APL-130277 in Patients With Parkinson's DiseaseCompletedNCT02228590Phase 2Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's DiseaseCompletedNCT02224664Phase 1Results posted
• Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's DiseaseCompletedNCT02212678Phase 2Results posted
• Effects of Cholinergic Augmentation on Measures of Balance and GaitCompletedNCT02206620Phase 2Results posted
• Open-Label Safety Study of ADS-5102 in PD Patients With LIDCompletedNCT02202551Phase 3Results posted
• Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis PatientsCompletedNCT02184494Not applicableResults posted
• Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's DiseaseCompletedNCT02183519Phase 1/2Results posted
• Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's DiseaseCompletedNCT02175472Not applicableResults posted
• The Effect of BIA 9-1067 at Steady-state on the Levodopa PharmacokineticsCompletedNCT02170376Phase 1Results posted
• Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/BenserazideCompletedNCT02169895Phase 1Results posted
• Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/CarbidopaCompletedNCT02169479Phase 1Results posted
• Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/BenserazideCompletedNCT02169466Phase 1Results posted
• Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/CarbidopaCompletedNCT02169453Phase 1Results posted
• Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of WarfarinCompletedNCT02169440Phase 1Results posted
• An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and MetabolitesCompletedNCT02169427Phase 1Results posted
• Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa PharmacokineticsCompletedNCT02169414Phase 1Results posted
• Efficacy of Isradipine in Early Parkinson DiseaseCompletedNCT02168842Phase 3Results posted
• Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's DiseaseTerminatedNCT02162979Phase 2Results posted
• Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.TerminatedNCT02153645Phase 3Results posted
• Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LIDTerminatedNCT02153632Phase 3Results posted
• Remote Access to Care, Everywhere, for Parkinson DiseaseCompletedNCT02144220Not applicableResults posted
• ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)CompletedNCT02136914Phase 3Results posted
• A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's DiseaseTerminatedNCT02134795Not applicableResults posted
• Impact of Walking Practice on Persons With PDTerminatedNCT02113189Not applicableResults posted
• Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic ImpairmentCompletedNCT02101190Phase 1Results posted
• A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)CompletedNCT02092181Phase 4Results posted
• Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young SubjectsCompletedNCT02092168Phase 1Results posted
• Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsCompletedNCT02091739Phase 3Results posted
• Comparative Bioavailability Study of BIA 9-1067 25 mg CapsulesCompletedNCT02071823Phase 1Results posted
• Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067CompletedNCT02071810Phase 1Results posted
• Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.CompletedNCT02064166Phase 2Results posted
• Pilot Study for Automated Deep Brain Stimulation ProgrammingCompletedNCT02046863Not applicableResults posted
• Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their HomesCompletedNCT02038959Not applicableResults posted
• Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's DiseaseTerminatedNCT02022735Not applicableResults posted
• Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's DiseaseCompletedNCT02006121Phase 3Results posted
• Erythromycin in Parkinson's DiseaseCompletedNCT02005029Not applicableResults posted
• DBS Under General Anesthesia: Comparison To The Standard TechniqueCompletedNCT01997398Results posted
• Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsCompletedNCT01994109Phase 3Results posted
• Neural Signatures of Parkinson's DiseaseCompletedNCT01990313Not applicableResults posted
• Amplitude and Rate of Intrinsic Feedback During Treadmill Training for Parkinson's DiseaseCompletedNCT01987557Not applicableResults posted
• Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)CompletedNCT01971008Phase 2Results posted
• Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's DiseaseCompletedNCT01968460Phase 2/3Results posted
• A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedNCT01968031Phase 3Results posted
• A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCompletedNCT01960842Phase 3Results posted
• Duodopa Home Titration Using Telemedicine: Evaluation of Use of ResourcesCompletedNCT01956032Results posted
• Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)CompletedNCT01952678Results posted
• Chronic Effects of DBS in Parkinson's Disease and DystoniaCompletedNCT01934296Not applicableResults posted
• A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.TerminatedNCT01929317Phase 3Results posted
• A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3Results posted
• CUSTOM-DBS: Current Steering to Optimize Deep Brain StimulationCompletedNCT01896115Not applicableResults posted
• A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease PatientsCompletedNCT01883505Phase 2Results posted
• Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous SystemCompletedNCT01877538Results posted
• Effects Of tDCS With Physical Therapy On Rehabilitation In Parkinson's DiseaseCompletedNCT01877148Phase 2Results posted
• Deep Brain Stimulation (DBS) for the Treatment of Parkinson's DiseaseCompletedNCT01839396Not applicableResults posted
• Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's DiseaseTerminatedNCT01798927Not applicableResults posted
• Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's DiseaseTerminatedNCT01789047Phase 2Results posted
• The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's DiseaseCompletedNCT01785628Not applicableResults posted
• Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And ApathyCompletedNCT01782222Phase 4Results posted
• ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's DiseaseCompletedNCT01772693Not applicableResults posted
• Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)CompletedNCT01770145Phase 4Results posted
• Exercise and Parkinson's: Comparing Interventions and Exploring Neural MechanismsCompletedNCT01768832Not applicableResults posted
• Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease PatientsCompletedNCT01767129Phase 2Results posted
• Global REsponsE During iNFusIon of a gEl With LevoDopa/CarbidopaCompletedNCT01754129Results posted
• Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility StudyCompletedNCT01750242Results posted
• A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country StudyCompletedNCT01747655Results posted
• Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainCompletedNCT01744496Phase 4Results posted
• A Pilot Study of Oxaloacetate in Subjects With Treated PDCompletedNCT01741701Phase 2/3Results posted
• Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)CompletedNCT01738191Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's DiseaseCompletedNCT01736176Phase 3Results posted
• A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's DiseaseCompletedNCT01723904Phase 3Results posted
• Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseCompletedNCT01723228Phase 4Results posted
• Effects of Dexmedetomidine on Activity in the Subthalamic NucleusCompletedNCT01721460Phase 4Results posted
• A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseCompletedNCT01711866Phase 4Results posted
• Clinical Outcomes of Deep Brain Stimulator (DBS) Electrodes Placed Using Intraoperative Computed Tomography (CT) and Frameless StereotaxisCompletedNCT01703598Not applicableResults posted
• Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial OvergrowthCompletedNCT01662791Phase 3Results posted
• Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/ParkinsonismCompletedNCT01653132Phase 2Results posted
• Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's DiseaseTerminatedNCT01652534Phase 3Results posted
• Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646268Phase 3Results posted
• Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646255Phase 3Results posted
• Telemedicine Intervention to Improve Physical FunctionCompletedNCT01639469Not applicableResults posted

← Parkinson Disease overview